share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/31 17:05
Moomoo AI 已提取核心信息
On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.
On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.
2024年5月28日,Conduit Pharmicals Inc.收到纳斯达克股票市场有限责任公司的通知,表明该公司没有遵守纳斯达克独立审计委员会的要求。这种违规行为发生在詹妮弗·麦克尼利女士辞去董事会和所有委员会的职务后,审计委员会只有两名独立董事。该公司有权在下一次年度股东大会的较早者或2025年5月13日之前恢复合规,如果年会在此日期之前举行,则将截止日期延长至2024年11月12日。该通知不影响该公司证券目前在纳斯达克的上市。Conduit Pharmicals计划通过在给定的时间范围内至少再任命一名独立董事加入审计委员会来解决这个问题。
2024年5月28日,Conduit Pharmicals Inc.收到纳斯达克股票市场有限责任公司的通知,表明该公司没有遵守纳斯达克独立审计委员会的要求。这种违规行为发生在詹妮弗·麦克尼利女士辞去董事会和所有委员会的职务后,审计委员会只有两名独立董事。该公司有权在下一次年度股东大会的较早者或2025年5月13日之前恢复合规,如果年会在此日期之前举行,则将截止日期延长至2024年11月12日。该通知不影响该公司证券目前在纳斯达克的上市。Conduit Pharmicals计划通过在给定的时间范围内至少再任命一名独立董事加入审计委员会来解决这个问题。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息